BOSTON--(BUSINESS WIRE)--Care Access, the world's leader in executing decentralized clinical trials at scale, has announced its upcoming involvement at four key industry conferences: CNS Summit, Outsourcing in Clinical Trials New England (OCTNE), Decentralized Trials & Research Alliance Annual Meeting (DTRA), and Decentralized Trials Digital Week. Care Access leaders will be onsite to discuss the common roadblocks to enrollment in clinical trials today; explore the potential of removing constraints imposed by traditional approaches to running clinical trials; and share examples of how the company’s innovative capabilities have helped sponsors to compress enrollment timelines and increase diversity in clinical trials. Care Access will also provide free COVID-19 rapid antigen testing for all attendees at the DTRA Annual Meeting and the CNS Summit.
“After a long 22 months, we’re thrilled to join these in-person industry-leading events to celebrate the advances the decentralized trial industry has made in the face of COVID-19,” said Ahmad Namvargolian, Care Access CEO. “Care Access strongly believes in delivering fast, predictable clinical trials by radically expanding and diversifying patient access, and these events provide us an opportunity to collaboratively discuss how to do that more effectively. It’s an honor to speak alongside some of the industry’s brightest and most talented leaders and organizations, and I look forward to building on our shared vision of imagining a more equitable and efficient clinical trial ecosystem.”
On the heels of a $220 million Series C Funding round, Care Access has continued to innovate and execute some of the industry’s most advanced clinical trials at scale. Through its participation in key events, the organization looks to continue this momentum and further its mission of bringing clinical research directly to patients, healthcare providers, and communities. Most notably, in its role as a founding member of DTRA, Care Access seeks to unite key stakeholders in groundbreaking decentralized research, as they share ideas, develop lasting connections, and collaborate on how to make patient-focused clinical trials accessible to everyone.
Highlights of Care Access’ upcoming presence at industry events include:
Providing COVID-19 Rapid Antigen Testing at the 12th Annual CNS Summit, Nov. 7-10 in Boston, MA. Booth #11
In addition to its booth presence, Care Access will provide rapid antigen testing for all event attendees to ensure the safety and security of all involved.
Participating on Panel at Outsourcing in Clinical Trials New England (OCTNE), Nov. 9-10 in Boston, MA. Booth #4
Vanessa Gertsen, Vice President of DCT Study Operations at Care Access, will join a panel discussion on lessons learned from the pandemic and implications for future clinical trials. The panel will be held on November 10 at 1:30 p.m.
Founding Member; Presenting and Providing COVID-19 Antigen Testing for All Attendees at Inaugural DTRA Annual Meeting, Nov. 10-13 in Boston, MA. Booth #11
Care Access CEO, Ahmad Namvargolian, will give a presentation on Decentralized Research Organizations (DRO) on November 11 at 1:00 p.m. Additionally, Care Access co-founder, Ralph Passarella, will join the panel discussion “Executing on the Mission in the Context of Explosive Growth” on November 12 at 11:25 a.m. Care Access will also provide antigen testing for all onsite attendees to ensure a safe and compliant event.
Executive Presentation at the Decentralized Trials Digital Week, Nov. 15, Virtual
Taking an active role in the 2021 event, Care Access’ CEO Ahmad Namvargolian will present a session titled “Virtual, Distributed, or Mobile: DCT strategies to reach more patients, contain costs, and enroll faster,” on November 15 at 12:00 p.m.
If you’re interested in learning more about Care Access, visit: www.careaccess.com.
About Care Access
Care Access is a leading decentralized research organization (DRO) that breaks down traditional barriers in clinical research for patients, sponsors, and physicians. Its innovative model brings decentralized trials, Sites On Demand™, Virtual PIs, and Mobile Sites to previously-unreachable patient populations to expand the impact of clinical research. Supported by top pharmaceutical and biotech partners across 20 different therapeutic areas, Care Access is scaling and globalizing its new model for clinical trial delivery, where more physicians and patients can engage in life-saving research to develop new therapies faster. To find out how Care Access is transforming the future of clinical trials, visit www.careaccess.com.